Risk Management
<< Back | Download |
YUTIQ Implant
The YUTIQ implant is approved for chronic non-infectious posterior uveitis. This form was created on 3/13/20.
Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website<< Back | Download |
The YUTIQ implant is approved for chronic non-infectious posterior uveitis. This form was created on 3/13/20.
Please refer to OMIC's Copyright and Disclaimer regarding the contents on this websiteA-rated by AM Best, OMIC is consistently ranked among the top malpractice insurance companies in America for financial stability. No other carrier has matched OMIC's consistent financial performance with regard to both combined, operating, and surplus ratios, the most relevant financial measurements for an insurance carrier.